Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
01 7Evonik
02 5Gangwal Healthcare
03 2Aeon Procare
04 3Alcedo Pharmachem
05 28BASF
06 7Corel Pharma Chem
07 2Gangwal Chemicals
08 6Ideal Cures Pvt Ltd
09 15Kerry
10 1Kima Chemical
11 1Lonza Capsugel
12 1Sigachi Industries
13 5The Dow Chemical Company
14 3Vertellus
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100, a functional delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5
Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A
Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® L 100
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5
Grade : Oral
Application : Co-Processed Excipients, Controlled & Modified Release, Direct Compression
Excipient Details : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.
Pharmacopoeia Ref : In-house
Technical Specs : NA
Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc
Brand : DICOM-DC® SR300
Pharmacopoeia Ref : In-house
Technical Specs : NA
Grade : Oral
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Brand Name : EUDRAGIT® L 100-55
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100-55 polymer is used in delayed, sustained-release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules, etc.
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® L 30 D-55
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Capsule, Granule / Pellet, Tablet
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® L 100-55
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® L 30 D-55
Grade : Oral
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® RL, an insoluble, highly permeable polymer used in combination with EUDRAGIT® RS in customized release drugs such as tablets, capsules, etc.
Pharmacopoeia Ref : NA
Technical Specs : Other grades- EUDRAGIT® RL 12,5, EUDRAGIT® RL 30 D, EUDRAGIT® RL PO
Ingredient(s) : Ammonia Methacrylate Copolymer Type A
Ingredient(s) : Ammonia Methacrylate Copolymer Type A
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® RL 100
Pharmacopoeia Ref : NA
Technical Specs : Other grades- EUDRAGIT® RL 12,5, EUDRAGIT® RL 30 D, EUDRAGIT® RL PO
Grade : Oral
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Application : Controlled & Modified Release
Excipient Details : Gellets-P are Microcrystalline Cellulose based spheres for the manufacturing of pellets and modified release products.
Pharmacopoeia Ref : In-house
Technical Specs : NA
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Capsule, Granule / Pellet, Tablet
Category : Controlled & Modified Release
Brand : GELLETS-P®
Applications : Gellets-P are Microcrystalline Cellulose based spheres for the manufacturing of pellets and modified release products.
Pharmacopoeia Ref : In-house
Technical Specs : NA
Grade : Oral